Blog Archives

June 30, 2026
The Concentration Paradox and Why Most Solutions Don’t Solve It
The standard tools for managing concentrated equity, selling, exchange funds, tender offers, all require the holder to give up the very conviction that built the position in the first place. There is a structurally different path, and most advisory conversations never get there.
June 30, 2026
What the Multiple Gap Is Really Telling Sponsors
The spread between upper and lower middle market entry multiples isn’t just a function of size. It’s the market pricing in how much real underwriting actually happened.
Two business leaders shaking hands across an executive desk, symbolizing trust, long-term relationships, and proprietary deal sourcing.
June 30, 2026
Proprietary Deal Flow Is a Lagging Indicator, Not a Strategy
Every firm claims off-market access, but almost none can explain why a specific seller called them first. The answer to that question is the difference between a sourcing pitch and the real thing.
Wooden blocks arranged into a stable structure on an executive desk, representing successful business integration and long-term value creation.
June 30, 2026
Why Buy-and-Build Strategies Are Getting Harder to Exit At the Multiples Sponsors Expected
Buy-and-build became the dominant playbook in the middle market because multiple arbitrage worked without much else. That window is closing, and what’s left is the integration work that was always the harder part.
Modern executive workspace featuring a chessboard, market charts, and financial objects symbolizing strategic decision-making in equity-backed lending.
June 30, 2026
Why Most Borrowers Don’t Fully Understand the Recourse They Have Actually Agreed To
Most borrowers assume their downside in a secured lending arrangement is capped at the collateral. In most structures, that assumption is softer than it looks on paper.
July 2, 2026
What the 10b5-1 Reforms Actually Changed for Executives
The 2022 amendments tightened a rule that needed tightening, but the friction fell on everyone, including executives who weren’t abusing the system. For those who never intended to sell in the first place, the more useful question is whether a trading plan was ever the right tool.
July 2, 2026
The Signal Cost of Selling
The financial math on a large insider sale is well understood. What rarely gets modeled is what that transaction communicates to the institutional investors watching the tape.
July 2, 2026
Why LPs Stopped Trusting IRR
Internal rate of return is easy to present favorably when you control the timing of capital calls and the mechanics of how assets are marked. Distributions to paid-in capital are harder to engineer, which is exactly why they’ve become the metric that matters.
July 2, 2026
Continuation Funds and the Question They Defer
Continuation vehicles have moved from niche to mainstream as a way to manage assets that can’t clear the market at an acceptable price. The structure buys time, but it doesn’t answer the underlying question about whether the original underwriting holds.
July 2, 2026
Why Passing on a Deal Is Sometimes the Most Important Thing a Firm Can Do
The fee structure of a conventional private equity firm rewards deployment, not judgment. Understanding that incentive is the starting point for understanding why so many deals that shouldn’t get done, do.
July 2, 2026
The Parts of Due Diligence That Don’t Show Up in a Data Room
Most firms treat character as a tiebreaker between otherwise comparable opportunities. Using it as a threshold, something a deal has to clear before financial analysis even begins, is a different standard, and it costs something to maintain.